Skip to main content
Home

Pulmonology

Main navigation

  • Pulmonology
    • COPD/Astma/Allergie
    • Digest
    • Infectieziekten
    • Oncologie
    • Overig
  • Medi-Access
background_placeholder
nsclc

Articles about nsclc

     
Kies meer
Thorax
In Wetenschap

Tumour-infiltrating bystander CD8+ T cells activated by IL-15 contribu...

Lung Cancer
In Wetenschap

Prospective multicenter cohort study of durvalumab for patients with u...

Lung Cancer
In Wetenschap

Effect of adherence to treatment guidelines on overall survival in eld...

The Doctors Lounge: Oncology
In Wetenschap

More Than 18 Million Cancer Survivors Living in U.S. as of Jan. 1, 202...

European Respiratory Review
In Wetenschap

Practical recommendations to combine small-molecule inhibitors and dir...

The Doctors Lounge: Oncology
In Wetenschap

ASCO: Ramucirumab Plus Pembrolizumab Promising in NSCLC

PMLiVE
In Wetenschap

EC approves Roche’s Tecentriq for early-stage lung cancer

British Journal of Cancer
In Wetenschap

Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—com...

Trending

Er zijn @count nieuwe artikelen
Monday, July 25, 2022 - 16:40 - In Wetenschap
Tumour-infiltrating bystander CD8+ T cells activated by IL-15 contribute to tumour control in non-small cell lung cancer
Wednesday, July 13, 2022 - 11:16 - In Wetenschap
Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis
Tuesday, July 12, 2022 - 11:32 - In Wetenschap
Effect of adherence to treatment guidelines on overall survival in elderly non-small-cell lung cancer patients
Friday, June 24, 2022 - 23:24 - In Wetenschap
More Than 18 Million Cancer Survivors Living in U.S. as of Jan. 1, 2022
Wednesday, June 15, 2022 - 09:24 - In Wetenschap
Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer
Thursday, June 9, 2022 - 23:40 - In Wetenschap
ASCO: Ramucirumab Plus Pembrolizumab Promising in NSCLC
Thursday, June 9, 2022 - 14:32 - In Wetenschap
EC approves Roche’s Tecentriq for early-stage lung cancer
Tuesday, May 31, 2022 - 12:32 - In Wetenschap
Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • ›› Next page
  • » Last page

Kies uw tags

luchtweginfectie
chronic airway inflammation
Ernstig astma
aspergillus fumigatus
pleural infection
lung carcinoma
copd
respiratory tract infection
legionella
lung cancer

Medzine logo gekleurd

Word op de hoogte gehouden van de laatste ontwikkelingen binnen Pulmonologie via MedZine. Het nieuws wordt samengesteld uit meer dan 4.700 wetenschappelijke journals, beroepsverenigingen en andere gezaghebbende websites.

Sitemap

  • Trending
  • Wetenschappelijk
  • Uw nieuws

Support

  • Contact
  • Privacyverklaring
  • Gebruik van cookies

Medix

FTO

CEFI

 CME Academy

FarmacoTherapie Online

Medi-Access